aim
sinc
randomis
clinic
trial
metaanalys
report
equal
efficaci
pain
relief
singleand
multiplefract
radiotherapi
bone
metastas
number
factor
includ
limit
radiotherapi
resourc
wait
time
patient
conveni
suggest
singl
fraction
treatment
choic
patient
howev
intern
pattern
practic
indic
multipl
fraction
still
commonli
use
studi
examin
whether
dosefraction
scheme
use
treatment
bone
metastas
rapid
respons
radiotherapi
program
rrrp
odett
cancer
centr
chang
sinc
materi
method
retrospect
review
prospect
rrrp
databas
hospit
record
conduct
patient
treat
palli
radiotherapi
uncompl
bone
metastas
rrrp
baselin
januari
juli
data
collect
patient
demograph
clinic
characterist
result
patient
prescrib
singl
fraction
predominantli
singl
gy
multipl
fraction
predominantli
gyfiv
fraction
respect
administr
singl
treatment
gener
increas
time
p
basi
multipl
logist
regress
analys
patient
like
prescrib
singlefract
radiotherapi
prostat
cancer
poorer
perform
statu
treat
limb
hip
shoulder
pelvi
rib
scapula
sternum
clavicl
compar
spine
treat
radiat
oncologist
train
earlier
year
treat
conclus
use
singlefract
radiotherapi
increas
correspond
public
show
equal
efficaci
pain
relief
singl
multipl
fraction
manag
uncompl
bone
metastas
howev
third
patient
still
receiv
multipl
fraction
bradley
n
e
et
al
estim
cancer
patient
receiv
palli
radiotherapi
cours
diseas
radiotherapi
highli
effect
therefor
commonli
use
palliat
bone
metastas
overal
complet
pain
respons
rate
respect
howev
controversi
exist
optim
dosefraction
regimen
treatment
bone
metastas
mani
randomis
clinic
trial
rct
dosefraction
schedul
conclud
singl
fraction
provid
equal
pain
relief
multipl
fraction
treatment
uncompl
bone
metastas
first
two
larg
multicentr
rct
confirm
equival
publish
follow
public
two
metaanalys
studi
basi
empir
result
provinc
ontario
publish
evidencebas
guidelin
recommend
use
singlefract
radiotherapi
manag
uncompl
bone
metastas
howev
contemporari
survey
pattern
practic
north
america
europ
australia
southeast
asia
suggest
radiat
oncologist
continu
use
multipl
fraction
treatment
bone
metastas
meanwhil
shortag
radiotherapi
resourc
includ
health
care
profession
technician
radiat
equip
histor
led
situat
overload
ontario
deliveri
time
radiotherapi
compromis
evid
increas
wait
time
radiat
servic
concern
provinci
health
polici
decisionmak
clinician
patient
limit
resourc
may
better
use
patient
bone
metastas
treat
singl
fraction
assum
equival
singl
multipl
fraction
radiotherapi
provid
pain
relief
moreov
two
three
survey
patient
prefer
show
patient
prefer
conveni
effect
treatment
modal
prefer
shorter
cours
palli
radiotherapi
bone
metastas
odett
cancer
centr
one
two
larg
cancer
centr
provid
radiotherapi
greater
toronto
area
rapid
respons
radiotherapi
program
rrrp
outpati
clinic
odett
cancer
centr
start
pilot
programm
ontario
provid
time
palli
radiotherapi
reduc
wait
time
radiotherapi
servic
ontario
patient
advanc
cancer
refer
programm
reliev
suffer
improv
symptom
qualiti
life
referr
rrrp
patient
pain
bone
metastas
patient
begin
treatment
day
initi
consult
radiat
oncologist
therefor
patient
prescrib
singl
fraction
typic
cancer
centr
day
studi
conduct
determin
whether
fraction
use
treatment
uncompl
bone
metastas
rrrp
chang
determin
evidencebas
research
find
translat
clinic
practic
among
radiat
oncologist
specialis
palli
radiotherapi
larg
radiat
treatment
centr
ontario
effect
patient
diseas
treatment
organis
factor
use
singl
vs
multipl
cours
palli
radiotherapi
also
consid
retrospect
review
prospect
databas
electron
treatment
record
physiciandict
progress
note
conduct
bone
metastas
patient
prescrib
palli
radiotherapi
rrrp
januari
juli
year
chosen
includ
time
period
public
landmark
rct
metaanalys
data
patient
chart
avail
electron
form
could
includ
review
year
select
intermediari
year
use
determin
chang
radiotherapi
prescript
public
two
rct
data
collect
data
collect
given
sever
acut
respiratori
syndrom
sar
outbreak
toronto
period
radiat
oncologist
like
prescrib
singlefract
radiotherapi
due
increas
chanc
infect
longer
stay
hospit
furthermor
data
collect
juli
given
time
constraint
data
collect
process
primari
outcom
interest
dosefraction
regimen
prescrib
gynumb
fraction
eight
demograph
clinic
variabl
shown
associ
dosefraction
regimen
prescrib
extract
medic
record
includ
gender
age
radiat
bone
metastas
primari
cancer
site
karnofski
perform
statu
kp
score
record
time
consult
distanc
resid
deriv
residenti
postal
code
cancer
centr
date
initi
consult
radiat
oncologist
boni
site
irradi
year
certif
royal
colleg
physician
surgeon
ontario
radiat
oncologist
primari
cancer
site
categoris
cancer
lung
breast
prostat
other
kp
valid
function
assess
tool
often
use
oncolog
patient
categor
interv
scale
rang
death
function
impair
kp
score
analys
continu
variabl
distanc
travel
resid
cancer
clinic
summaris
continu
ordin
categor
variabl
near
km
intermedi
km
distant
km
distant
km
dichotom
variabl
near
km
distant
km
irradi
bone
metastas
site
group
five
categori
spine
pelvi
rib
scapula
sternum
clavicl
chest
limb
hip
shoulder
skull
hemibodi
irradi
year
certif
treat
radiat
oncologist
record
patient
case
categoris
decad
exclud
analysi
patient
document
spinal
cauda
equina
compress
nerv
root
imping
actual
impend
patholog
fractur
extrem
previous
irradi
boni
lesion
referr
postop
radiotherapi
bone
uncertainti
presenc
spinal
cord
compress
patholog
fractur
impend
cord
compress
fractur
crosscheck
avail
imag
report
data
collect
episod
radiotherapi
bone
metastas
januari
juli
ethic
approv
research
involv
human
obtain
hospit
research
ethic
board
descript
statist
record
percentag
proport
mean
median
standard
deviat
rang
continu
variabl
purpos
studi
dosefraction
regimen
patient
code
binari
variabl
singl
fraction
multipl
fraction
patient
one
independ
cours
radiotherapi
bone
metastas
studi
period
one
cours
radiat
randomli
select
use
tabl
random
number
determin
whether
use
singlefract
radiotherapi
chang
time
chisquar
test
use
chisquar
test
also
use
detect
differ
proport
unord
categor
variabl
includ
gender
travel
distanc
primari
cancer
site
site
radiotherapi
prescript
singl
multipl
fraction
radiat
oncologist
year
certif
radiat
oncologist
across
time
continu
interv
variabl
age
travel
distanc
test
across
time
use
analysi
varianc
anova
univari
logist
regress
analys
conduct
identifi
patient
treatment
organis
variabl
significantli
associ
p
use
singlefract
regimen
model
multilevel
categor
variabl
dummi
code
follow
refer
group
femal
gender
lung
primari
cancer
site
near
travel
distanc
spine
radiotherapi
site
group
year
certif
radiat
oncologist
carri
multipl
logist
regress
analysi
examin
effect
year
treatment
refer
group
use
singl
radiotherapi
adjust
gender
age
primari
cancer
site
kp
travel
distanc
cancer
centr
site
radiotherapi
year
certif
radiat
oncologist
covari
includ
final
model
hypothesis
relat
prescript
singlefract
radiat
across
time
final
model
select
base
highest
r
valu
statist
indic
best
fit
model
patient
miss
valu
covari
exclud
multipl
logist
regress
analysi
multicollinear
assess
use
correl
coeffici
varianc
inflat
factor
condit
indic
hosmerelemeshow
goodnessoffit
test
conduct
determin
data
fit
specifi
model
analys
carri
use
statist
analysi
system
sa
version
test
consid
statist
signific
p
valu
confid
interv
includ
one
test
twosid
studi
sampl
consist
patient
symptomat
uncompl
bone
metastas
total
cours
palli
radiotherapi
prescrib
tabl
present
clinic
activ
demograph
diseas
treatmentrel
characterist
patient
year
studi
clinic
activ
refer
number
patient
prescrib
radiotherapi
bone
metastas
well
number
cours
radiotherapi
bone
metastas
prescrib
year
studi
randomli
select
one
cours
radiotherapi
per
patient
patient
prescrib
singl
multipl
fraction
radiat
respect
singlefract
treatment
predominantli
prescrib
gy
dose
rang
gy
nineti
per
cent
multiplefract
treatment
prescrib
gyfiv
fraction
fraction
rang
gytwo
fraction
fraction
proport
singl
fraction
use
time
present
fig
administr
singl
treatment
gener
increas
across
time
p
overal
sampl
men
mean
age
year
three
common
primari
cancer
site
lung
prostat
breast
respect
median
kp
score
indic
patient
requir
occasion
assist
other
abl
care
need
radiotherapi
episod
spine
pelvi
limb
median
travel
distanc
clinic
km
patient
resid
near
cancer
centr
distanc
less
km
test
heterogen
found
signific
differ
proport
men
women
prescrib
radiotherapi
p
across
time
proport
men
increas
distribut
primari
cancer
site
also
chang
p
across
time
increas
proport
lung
prostat
cancer
decreas
frequenc
breast
cancer
cancer
type
furthermor
patient
prescrib
radiotherapi
poorer
perform
statu
median
patient
seen
median
p
tabl
tabl
present
univari
relationship
individu
clinic
demograph
variabl
singlefract
radiotherapi
shown
patient
treat
singlefract
radiotherapi
significantli
older
mean
age
year
patient
treat
multipl
fraction
mean
age
year
increas
year
age
patient
time
greater
odd
receiv
singlefract
radiat
patient
prostat
cancer
time
odd
receiv
singlefract
radiat
compar
patient
lung
cancer
signific
differ
use
singl
multipl
fraction
patient
breast
type
cancer
odd
ratio
respect
tabl
patient
higher
kp
lower
odd
receiv
singlefract
radiat
patient
poorer
perform
statu
odd
ratio
confid
interv
also
patient
live
distant
treatment
centr
time
odd
confid
interv
receiv
singl
fraction
radiotherapi
compar
patient
live
near
cancer
centr
overal
signific
differ
use
singlefract
radiotherapi
boni
site
metastas
p
singl
fraction
use
frequent
irradi
limb
hip
pelvi
rib
compar
treatment
spine
tabl
signific
differ
prescript
singleor
multiplefract
radiat
accord
year
certif
radiat
oncologist
oncologist
certifi
like
prescrib
singlefract
radiat
certifi
odd
ratio
respect
howev
differ
prescript
pattern
oncologist
certifi
compar
year
counterpart
gender
found
associ
singlefract
radiat
tabl
result
multivari
logist
regress
analys
also
present
tabl
adjust
gender
age
primari
cancer
site
kp
distanc
travel
ordin
measur
site
radiotherapi
year
certif
radiat
oncologist
significantli
increas
likelihood
singlefract
radiat
prescrib
odd
use
singlefract
radiat
time
greater
overal
tabl
increas
use
singlefract
radiat
observ
kp
site
radiat
year
certif
oncologist
also
significantli
associ
dosefraction
regimen
treatment
pelvi
time
odd
receiv
singlefract
radiat
wherea
treatment
rib
scapula
sternum
clavicl
time
odd
receiv
singlefract
radiat
compar
treatment
spine
also
treatment
limb
hip
shoulder
time
odd
receiv
singlefract
radiat
compar
treatment
spine
control
age
primari
cancer
site
overal
found
relat
singlefract
radiat
although
prostat
cancer
patient
greater
likelihood
odd
ratio
prescrib
singlefract
radiat
compar
cancer
site
oncologist
train
earlier
year
ie
significantli
higher
odd
prescrib
singlefract
radiat
oncologist
train
later
collinear
present
multivari
model
varianc
inflat
factor
rang
result
hosmerelemeshow
goodnessoffit
test
indic
evid
gross
lack
fit
model
p
studi
provid
insight
knowledg
translat
empir
evid
rct
palli
radiotherapi
clinic
set
basi
review
practic
rrrp
use
singlefract
radiat
increas
significantli
time
particularli
public
two
larg
rct
two
metaanalys
similarli
rapid
chang
pattern
practic
concurr
chemotherapi
radiat
cervic
cancer
ontario
also
shown
respons
public
rct
recommend
nation
cancer
institut
declin
prescript
singlefract
radiat
compar
although
odd
administr
singlefract
radiotherapi
significantli
higher
odd
ratio
confid
interv
metaanalys
evidencebas
practic
guidelin
ontario
overal
singlefract
radiotherapi
use
frequent
among
rrrp
oncologist
compar
nation
pattern
practic
survey
conduct
june
respond
would
use
singlefract
radiotherapi
offici
department
polici
dosefraction
schedul
bone
metastas
establish
odett
cancer
centr
year
review
likewis
financi
incent
canadian
radiat
oncologist
prescrib
one
fraction
radiat
paid
per
fraction
radiat
deliv
knowledg
howev
one
publish
studi
examin
chang
use
singlefract
radiotherapi
bone
metastas
time
similar
palli
radiat
clinic
haddad
et
al
conduct
review
dose
fraction
use
treatment
bone
metastas
palli
radiat
oncolog
program
prop
princess
margaret
hospit
pmh
toronto
ontario
like
rrrp
prop
provid
quick
access
palli
radiotherapi
larg
radiat
treatment
centr
prop
patient
profil
compar
rrrp
term
primari
cancer
site
gender
age
skelet
site
metastas
overal
singlefract
radiotherapi
use
greater
frequenc
among
evalu
rrrp
patient
compar
prop
patient
vs
respect
clinic
frequent
prescrib
singleand
multiplefract
treatment
regimen
singl
gy
gyfiv
fraction
respect
prop
use
singlefract
radiotherapi
gener
increas
declin
indic
fig
rel
proport
use
singlefract
radiotherapi
much
higher
rrrp
period
radiotherapi
case
respect
known
reason
account
differ
use
singlefract
radiotherapi
prop
rrrp
clinic
survey
radiat
oncologist
pmh
conduct
investig
factor
guid
prescript
fraction
practic
bone
metastas
survey
found
would
prescrib
singlefract
radiat
bone
metastas
eightyeight
per
cent
report
use
perform
statu
age
respect
guid
choic
dosefraction
schedul
less
oncologist
use
locat
lesion
vertebra
weightbear
bone
survey
conduct
uk
found
radiat
oncologist
normal
prefer
singlefract
radiotherapi
palliat
bone
metastas
would
use
multipl
fraction
case
involv
younger
age
eg
year
cervic
spine
metastas
neurolog
symptom
associ
spinal
metastas
diagnos
singl
bone
lesion
lytic
metastas
hand
oncologist
normal
prefer
use
multipl
fraction
radiotherapi
would
use
singlefract
radiat
case
involv
older
patient
ie
r
year
patient
travel
treatment
temporari
wait
list
resourc
avail
pressur
rib
metastas
lung
cancer
patient
result
multivari
logist
regress
model
suggest
increas
use
singlefract
radiotherapi
time
rrrp
remain
adjust
gender
age
kp
primari
cancer
site
distanc
travel
resid
centr
site
radiat
year
certif
radiat
oncologist
although
administr
singl
fraction
hypothesis
like
patient
travel
distanc
resid
centr
adjust
covari
distanc
signific
factor
dosefraction
regimen
prescrib
result
also
suggest
experi
radiat
oncologist
quantit
greater
influenc
use
singl
fraction
year
treatment
odd
ratio
oncologist
certifi
respect
compar
treatment
respect
expect
cohort
effect
experienc
oncologist
train
earlier
year
may
like
give
singlefract
radiotherapi
like
base
clinic
practic
empir
evid
experienc
oncologist
train
earlier
year
may
confid
know
appli
result
empir
evid
clinic
practic
howev
observ
differ
prescript
pattern
oncologist
warrant
investig
difficult
confid
ascertain
whether
increas
use
singlefract
radiotherapi
time
rrrp
due
effect
empir
evid
recommend
literatur
due
factor
person
prefer
radiat
oncologist
patient
prefer
patient
tumourrel
characterist
examin
studi
limit
factor
beyond
control
research
resourc
studi
one
cours
palli
radiat
randomli
select
patient
case
may
overlook
difficult
know
whether
previou
cours
radiotherapi
confound
use
singl
multipl
fraction
subsequ
treatment
bone
metastas
similar
pmh
review
estim
patient
surviv
life
expect
treat
radiat
oncologist
consist
avail
patient
record
includ
potenti
covari
dosefraction
prescript
data
wait
time
referr
radiotherapi
consult
collect
studi
hypothesis
variabl
could
influenc
use
singl
multipl
fraction
across
time
depend
pressur
radiat
wait
time
within
radiotherapi
depart
well
within
rrrp
clinic
pmh
review
wait
time
radiat
found
influenc
use
singl
multipl
fraction
also
specif
tumour
characterist
record
lesion
type
lytic
blastic
mix
date
diagnosi
primari
cancer
site
bone
metastas
number
boni
lesion
site
metastas
extent
diseas
data
inconsist
avail
electron
patient
record
furthermor
data
field
size
radiat
deliv
collect
studi
could
influenc
oncologist
decis
dosefraction
choic
diseaserel
factor
may
influenc
dosefraction
prescript
pattern
lastli
data
radiat
oncologist
subspecialti
collect
studi
overal
cours
palli
radiotherapi
bone
metastas
programm
prescrib
singl
fraction
result
studi
suggest
practic
significantli
chang
rrrp
public
influenti
rct
recommend
treatment
increas
prescript
singlefract
radiotherapi
pain
bone
metastas
time
rrrp
signific
chang
follow
public
two
larg
rct
two
metaanalys
confirm
equival
pain
relief
singl
multipl
fraction
respect
potenti
contribut
factor
dosefraction
schedul
includ
site
bone
metastas
physicianrel
factor
oblig
exist
use
costeffect
treatment
plan
provid
equival
outcom
order
provid
best
medic
care
optimis
resourc
publicli
privat
fund
region
world
recent
increas
use
singlefract
radiotherapi
treatment
bone
metastas
shown
reduc
overal
radiotherapi
workload
uk
reduct
radiat
workload
allow
increas
avail
radiat
resourc
potenti
reduc
radiat
wait
time
patient
potenti
cure
time
access
radiat
essenti
prevent
tumour
growth
metastasi
patient
may
also
benefit
use
singlefract
radiat
spare
addit
travel
treatment
time
mani
studi
alreadi
promot
advoc
use
singlefract
radiat
also
advoc
use
singlefract
radiat
acknowledg
need
individu
casebas
manag
complic
bone
metastas
research
manag
patient
complic
bone
metastas
need
determin
use
multipl
fraction
appropri
controversi
dose
fraction
use
neuropath
pain
spinal
cord
compress
